BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27458253)

  • 1. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development.
    Chakraborty C; Roychowdhury A; Samadder S; Roy A; Mandal RK; Basu P; Roychoudhury S; Panda CK
    Biochem J; 2016 Oct; 473(19):3221-36. PubMed ID: 27458253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Wnt-β-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma.
    Chakraborty C; Samadder S; Roychowdhury A; Roy A; Das P; Mandal RK; Roychoudhury S; Panda CK
    Mol Cell Biochem; 2018 Jun; 443(1-2):121-130. PubMed ID: 29079964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
    Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
    Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
    Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication.
    Chakraborty C; Dutta S; Mukherjee N; Samadder S; Roychowdhury A; Roy A; Mondal RK; Basu P; Roychoudhury S; Panda CK
    Tumour Biol; 2015 Feb; 36(2):1143-54. PubMed ID: 25330948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.
    Sarkar S; Alam N; Mandal SS; Chatterjee K; Ghosh S; Roychoudhury S; Panda CK
    PLoS One; 2018; 13(4):e0195937. PubMed ID: 29672635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Zabarovsky ER; Roy A; Roychoudhury S; Panda CK
    Cancer Sci; 2010 Jun; 101(6):1511-20. PubMed ID: 20412120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
    Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.
    Mazumder Indra D; Mitra S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Chakravarty R; Panda CK
    Hum Genet; 2011 Dec; 130(6):735-48. PubMed ID: 21643982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
    Dutta P; Pal D; Roy A; Mandal RK; Panda CK
    Gene; 2023 Dec; 888():147746. PubMed ID: 37657688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications.
    Dutta P; Basu M; Roy A; Mandal RK; Panda CK
    J Mol Histol; 2023 Feb; 54(1):89-102. PubMed ID: 36692670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of CHEK1 and EI24 is associated with the development of invasive cervical carcinoma: clinical and prognostic implications.
    Mazumder Indra D; Mitra S; Singh RK; Dutta S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Panda CK
    Int J Cancer; 2011 Oct; 129(8):1859-71. PubMed ID: 21154811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances.
    Mitra S; Mazumder-Indra D; Mondal RK; Basu PS; Roy A; Roychoudhury S; Panda CK
    PLoS One; 2012; 7(6):e38342. PubMed ID: 22719878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions.
    McCluggage WG; Maxwell P; Bharucha H
    Int J Gynecol Pathol; 1998 Jan; 17(1):29-35. PubMed ID: 9475189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications.
    Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
    Mol Carcinog; 2010 Nov; 49(11):935-43. PubMed ID: 20721974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metaphase-arrest technique applied to human cervical epithelium. II. Cell production rates in normal and pathological cervical epithelium.
    Ireland D
    Cell Tissue Kinet; 1985 May; 18(3):321-31. PubMed ID: 3986873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation during cervical carcinogenesis.
    Virmani AK; Muller C; Rathi A; Zoechbauer-Mueller S; Mathis M; Gazdar AF
    Clin Cancer Res; 2001 Mar; 7(3):584-9. PubMed ID: 11297252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
    Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
    Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor suppressor gene RBSP3 in cervical carcinoma: copy number and transcriptional level].
    Anedchenko EA; Kiseleva NP; Dmitriev AA; Kiselev FL; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2007; 41(1):86-95. PubMed ID: 17380895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.